Source: Covexit.com

video

This is a far ranging interview with Steve Kirsch, the founder of the COVID-19 Early Treatment Fund. The interview covers, inter alia, early outpatient treatment, vaccination, governmental responses to the pandemic, the role of tech companies and freedom of expression.

Steve Kirsch is a serial entrepreneur, the inventor of the optical mouse and a philanthropist.

There are also remarks by 2 medical doctors who practice early outpatient treatment and 2 participants in the ClubHouse session, which were recorded with permission.

Note: The audio version of the interview includes not only the interview, found on the video version, but also the beginning of the Q&A session, with interventions of Dr Fareed, Dr Bernstein and 2 participants in the audience.




Related:
A Conversation With Dr. Brian Tyson – The Chloroquine Wars Part XLI

Dr. Brian Tyson, USA: Hydroxychloroquine – Data, Strategies and Success Treating over 6000 Covid Patients

Hydroxychloroquine and its friends

Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk COVID-19 infection includes HCQ & Ivermectin

The Chloroquine Wars Part VIII – Hydroxychloroquine’s Safety Profile and a Cost-Benefit Analysis

Is the vaccine safe? Undoing the spin on the vaccine. We have safe and effective treatment options for COVID.

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Trouble in Paradise Surrounding the use of Ivermectin

In nations around the world tension mounts between physicians and caregivers seeking to prescribe what they professionally deem as safe doses of ivermectin, as an off-label treatment for COVID-19 and national health authorities, which for the most part have all taken a hostile and oppositional position against the use of the drug.

Read More »

How Ivermectin became a Target for the ‘Fraud Detectives.’

And why is ivermectin being so negatively targeted by Big Tech and Big Media? One could argue conflict of interest plays a major role, given how intertwined they are with Big Pharma and the far-reaching grasp of the BMGF. A cheap and effective early treatment for Covid-19, like ivermectin, can be seen as a significant threat to the financial interests of those involved with Covid vaccines and expensive anti-viral drugs.

Read More »

Canada: Alberta Failing on COVID-19 Vaccines and Treatment

Numerous studies and clinical observation of thousands of patients has indicated that Ivermectin is highly effective in this regard. Even low dose studies that were designed to reach the conclusion that ivermectin was not effective found a signal that indicated that Ivermectin effectively interacted with the COVID virus molecule to prevent or lessen replication of the virus.”

Read More »